{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:41:37Z","timestamp":1768714897182,"version":"3.49.0"},"reference-count":106,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/gco.0000000000000087","type":"journal-article","created":{"date-parts":[[2014,6,29]],"date-time":"2014-06-29T21:48:06Z","timestamp":1404078486000},"page":"226-236","source":"Crossref","is-referenced-by-count":29,"title":["Maximizing the clinical utility of antim\u00fcllerian hormone testing in women's health"],"prefix":"10.1097","volume":"26","author":[{"given":"Benjamin","family":"Leader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-mullerian hormone in women.","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.fertnstert.2012.11.051","article-title":"Biomarkers of ovarian response: current and future applications.","volume":"99","author":"Nelson","year":"2013","journal-title":"Fertil Steril"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.fertnstert.2012.09.036","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion.","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/molehr\/gat024","article-title":"Which follicles make the most anti-mullerian hormone in humans Evidence for an abrupt decline in AMH production at the time of follicle selection.","volume":"19","author":"Jeppesen","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"E1649","DOI":"10.1210\/jc.2011-3133","article-title":"Differential regulation of ovarian antimullerian hormone (AMH) by estradiol through alpha- and beta-estrogen receptors.","volume":"97","author":"Grynberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0974-1208.117168","article-title":"Follicular-fluid anti-mullerian hormone (FF AMH) is a plausible biochemical indicator of functional viability of oocyte in conventional in vitro fertilization (IVF) cycles.","volume":"6","author":"Mehta","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2012.04.013","article-title":"Normal serum anti-mullerian hormone levels in the general female population and the relationship with reproductive history.","volume":"163","author":"La Marca","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.fertnstert.2013.10.021","article-title":"Reference range for the antimullerian hormone Generation II assay: a population study of 10984 women, with comparison to the established Diagnostics Systems Laboratory nomogram.","volume":"101","author":"Nelson","year":"2014","journal-title":"Fertil Steril"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.fertnstert.2010.08.022","article-title":"Nomogram for the decline in serum antimullerian hormone: a population study of 9601 infertility patients.","volume":"95","author":"Nelson","year":"2011","journal-title":"Fertil Steril"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rbmo.2011.05.006","article-title":"External validation of nomogram for the decline in serum anti-mullerian hormone in women: a population study of 15834 infertility patients.","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.fertnstert.2012.06.006","article-title":"High frequency of discordance between antimullerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5354 women in U.S. fertility centers.","volume":"98","author":"Leader","year":"2012","journal-title":"Fertil Steril"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","article-title":"Age-specific serum anti-mullerian hormone values for 17120 women presenting to fertility centers within the United States.","volume":"95","author":"Seifer","year":"2011","journal-title":"Fertil Steril"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum anti-mullerian hormone from conception to menopause.","volume":"6","author":"Kelsey","year":"2011","journal-title":"PLoS One"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.rbmo.2013.07.008","article-title":"Anti-mullerian hormone versus antral follicle count for defining the starting dose of FSH.","volume":"27","author":"Lan","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.fertnstert.2013.03.031","article-title":"Does the time interval between antimullerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist A retrospective single-center study.","volume":"100","author":"Polyzos","year":"2013","journal-title":"Fertil Steril"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/humrep\/det034","article-title":"A prediction model to select PCOS patients suitable for IVM treatment based on anti-mullerian hormone and antral follicle count.","volume":"28","author":"Guzman","year":"2013","journal-title":"Hum Reprod"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2014.02.020","article-title":"The dynamics of serum anti-mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.","volume":"176","author":"Weintraub","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.fertnstert.2013.09.028","article-title":"Impact of antimullerian hormone assays on the outcomes of in vitro fertilization: a prospective controlled study.","volume":"101","author":"Aboulghar","year":"2014","journal-title":"Fertil Steril"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction.","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-3-20210129","first-page":"0000000162","article-title":"Which tools may help physicians in female fertility prediction after autologous bone marrow transplantation for lymphoma A pilot study.","volume":"1973947813Y","author":"Pup","year":"2014","journal-title":"J Chemother"},{"key":"R24-3-20210129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09513590.2014.899572","article-title":"Role of baseline antral follicle count and anti-mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers.","volume":"30","author":"Li","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10815-014-0193-4","article-title":"Anti-mullerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.","volume":"31","author":"Lehmann","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","article-title":"Determining an anti-mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve.","volume":"30","author":"Merhi","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10815-013-9973-5","article-title":"The predictive value of anti-mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET).","volume":"30","author":"Lin","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"R28-3-20210129","first-page":"9","article-title":"Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.","volume":"57","author":"Himabindu","year":"2013","journal-title":"Indian J Physiol Pharmacol"},{"key":"R29-3-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-6-3","article-title":"External validation of anti-mullerian hormone based prediction of live birth in assisted conception.","volume":"6","author":"Khader","year":"2013","journal-title":"J Ovarian Res"},{"key":"R30-3-20210129","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature.","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R31-3-20210129","doi-asserted-by":"crossref","first-page":"e81629","DOI":"10.1371\/journal.pone.0081629","article-title":"Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles.","volume":"8","author":"Kedem","year":"2013","journal-title":"PLoS One"},{"key":"R32-3-20210129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2013.10.007","article-title":"AMH concentration is not related to effective time to pregnancy in women who conceive naturally.","volume":"28","author":"Streuli","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"R33-3-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7827-11-61","article-title":"Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility.","volume":"11","author":"Murto","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"R34-3-20210129","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2013-1235","article-title":"Study of anti-mullerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.","volume":"98","author":"Morel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-3-20210129","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.fertnstert.2012.01.128","article-title":"Executive summary of the stages of Reproductive Aging Workshop 10 addressing the unfinished agenda of staging reproductive aging.","volume":"97","author":"Harlow","year":"2012","journal-title":"Fertil Steril"},{"key":"R36-3-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/humrep\/det446","article-title":"Anti-mullerian hormone is a more accurate predictor of individual time to menopause than mothers age at menopause.","volume":"29","author":"Dolleman","year":"2014","journal-title":"Hum Reprod"},{"key":"R37-3-20210129","first-page":"1","article-title":"Predicting menopausal age with anti-mullerian hormone: a cross-validation study of two existing models.","volume":"10","author":"Ramezani Tehrani","year":"2014","journal-title":"Climacteric"},{"key":"R38-3-20210129","doi-asserted-by":"crossref","first-page":"e57005","DOI":"10.1371\/journal.pone.0057005","article-title":"Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status.","volume":"8","author":"La Marca","year":"2013","journal-title":"PLoS One"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"818912","DOI":"10.1155\/2013\/818912","article-title":"Potential mechanisms for racial and ethnic differences in antimullerian hormone and ovarian reserve.","volume":"2013","author":"Tal","year":"2013","journal-title":"Int J Endocrinol"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/GME.0b013e3182611574","article-title":"Role of antimullerian hormone as a biomarker of the menopausal transition.","volume":"20","author":"Iino","year":"2013","journal-title":"Menopause"},{"key":"R41-3-20210129","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1210\/jc.2012-4228","article-title":"The relationship between anti-mullerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.","volume":"98","author":"Dolleman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-3-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","article-title":"Medicine; Society for Assisted Reproductive TechnologyMature oocyte cryopreservation: a guideline.","volume":"99","year":"2013","journal-title":"Fertil Steril"},{"key":"R43-3-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/09513590.2013.777415","article-title":"The role of serum anti-mullerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.","volume":"29","author":"Casadei","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R44-3-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10815-013-0149-0","article-title":"Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms.","volume":"31","author":"Sahmay","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"R45-3-20210129","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti-mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum Reprod"},{"key":"R46-3-20210129","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-mullerian hormone predict the diagnosis of polycystic ovary syndrome A systematic review and meta-analysis of extracted data.","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-3-20210129","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcma.2011.12.007","article-title":"Anti-mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women.","volume":"75","author":"Chao","year":"2012","journal-title":"J Chin Med Assoc"},{"key":"R48-3-20210129","first-page":"883","article-title":"Antimullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVFICSI.","volume":"11","author":"Swellam","year":"2013","journal-title":"Iran J Reprod Med"},{"key":"R49-3-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/09513590.2013.864273","article-title":"Anti-mullerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.","volume":"30","author":"Tian","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R51-3-20210129","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/09513590.2013.867320","article-title":"Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology.","volume":"30","author":"Sahmay","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R52-3-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/GCO.0b013e328364ed2a","article-title":"Primary ovarian insufficiency in the adolescent.","volume":"25","author":"Baker","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R53-3-20210129","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/humrep\/der473","article-title":"Anti-mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.","volume":"27","author":"Kallio","year":"2012","journal-title":"Hum Reprod"},{"key":"R54-3-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrendo.2011.224","article-title":"Anti-mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency.","volume":"8","author":"Visser","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"R55-3-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13697137.2013.870149","article-title":"Elevated LH levels draw a stronger distinction than AMH in premature ovarian insufficiency.","volume":"17","author":"Sahmay","year":"2014","journal-title":"Climacteric"},{"key":"R56-3-20210129","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/humrep\/det384","article-title":"Association study of anti-mullerian hormone and anti-mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.","volume":"28","author":"Yoon","year":"2013","journal-title":"Hum Reprod"},{"key":"R57-3-20210129","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/humrep\/der146","article-title":"Intra-individual stability over time of standardized anti-mullerian hormone in FMR1 premutation carriers.","volume":"26","author":"Spath","year":"2011","journal-title":"Hum Reprod"},{"key":"R58-3-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1477-7827-11-80","article-title":"FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors.","volume":"11","author":"Gleicher","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"R59-3-20210129","doi-asserted-by":"crossref","first-page":"e33638","DOI":"10.1371\/journal.pone.0033638","article-title":"The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve.","volume":"7","author":"Gleicher","year":"2012","journal-title":"PLoS One"},{"key":"R60-3-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1477-7827-10-77","article-title":"Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene.","volume":"10","author":"Gleicher","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"R61-3-20210129","first-page":"1024","article-title":"Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test Acta Obstet Gynecol S","volume":"88","author":"Gleicher","year":"2009","journal-title":"cand"},{"key":"R62-3-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejogrb.2013.05.002","article-title":"The relationship between the number of CGG repeats and serum level of anti-mullerian hormone in women without FMR1 premutation.","volume":"169","author":"Choe","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R63-3-20210129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/GME.0000000000000139","article-title":"Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.","volume":"21","author":"Kline","year":"2014","journal-title":"Menopause"},{"key":"R64-3-20210129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/GCO.0b013e32833b6c70","article-title":"Primary ovarian insufficiency: autoimmune causes.","volume":"22","author":"La Marca","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R65-3-20210129","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/jwh.2013.4255","article-title":"Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.","volume":"22","author":"Ma","year":"2013","journal-title":"J Womens Health"},{"key":"R66-3-20210129","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0961203311409272","article-title":"Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-mullerian hormone.","volume":"20","author":"Lawrenz","year":"2011","journal-title":"Lupus"},{"key":"R67-3-20210129","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.crohns.2012.03.003","article-title":"Serum anti-mullerian hormone levels are lower in reproductive-age women with Crohns disease compared to healthy control women.","volume":"7","author":"Senates","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R68-3-20210129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/IGC.0b013e318270ac69","article-title":"Anti-mullerian hormone level in older women: detection of granulosa cell tumor recurrence.","volume":"22","author":"Chong","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"R69-3-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.gyobfe.2013.06.005","article-title":"Granulosa cell tumor: difficulty of diagnosis and contribution of imaging.","volume":"41","author":"Mancaux","year":"2013","journal-title":"Gynecol Obstet Fertil"},{"key":"R70-3-20210129","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.fertnstert.2014.01.052","article-title":"Increased expression of antimullerian hormone and its receptor in endometriosis.","volume":"101","author":"Carrarelli","year":"2014","journal-title":"Fertil Steril"},{"key":"R72-3-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.rbmo.2013.04.016","article-title":"Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve.","volume":"27","author":"Urman","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"R73-3-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.fertnstert.2013.10.019","article-title":"The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometriomas.","volume":"101","author":"Alborzi","year":"2014","journal-title":"Fertil Steril"},{"key":"R74-3-20210129","first-page":"240","article-title":"Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve.","volume":"36","author":"Arthur","year":"2014","journal-title":"J Obstet Gynaecol"},{"key":"R75-3-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5468\/ogs.2014.57.2.121","article-title":"Surgical impact on serum anti-mullerian hormone in women with benign ovarian cyst: a prospective study.","volume":"57","author":"Jang","year":"2014","journal-title":"Obstet Gynecol Sci"},{"key":"R76-3-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2013.10.003","article-title":"Evaluation of serum anti-mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis.","volume":"172","author":"Pacchiarotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R78-3-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-12-26","article-title":"Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review.","volume":"12","author":"Peigne","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"R79-3-20210129","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/1471-0528.12715","article-title":"Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, andor bone marrow transplantation for childhood malignant and nonmalignant diseases.","volume":"121","author":"Beneventi","year":"2014","journal-title":"BJOG"},{"key":"R80-3-20210129","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-014-2891-0","article-title":"Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.","volume":"144","author":"Ruddy","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R81-3-20210129","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-014-2860-7","article-title":"Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study.","volume":"144","author":"Hadji","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R82-3-20210129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1634\/theoncologist.2013-0145","article-title":"Prediction of postchemotherapy ovarian function using markers of ovarian reserve.","volume":"19","author":"Henry","year":"2014","journal-title":"Oncologist"},{"key":"R83-3-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000346139","article-title":"Low serum concentrations of anti-mullerian hormone are common in 53 female childhood cancer survivors.","volume":"79","author":"Miyoshi","year":"2013","journal-title":"Hormone Res Paediatr"},{"key":"R84-3-20210129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/art.37719","article-title":"Antimullerian hormone and ovarian reserve in systemic lupus erythematosus.","volume":"65","author":"Mok","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R85-3-20210129","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.fertnstert.2013.10.043","article-title":"Decline of serum antimullerian hormone levels after laparoscopic ovarian cystectomy in endometrioma and other benign cysts: a prospective cohort study.","volume":"101","author":"Kwon","year":"2014","journal-title":"Fertil Steril"},{"key":"R86-3-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7827-12-18","article-title":"The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM.","volume":"12","author":"Ortega-Hrepich","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"R87-3-20210129","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2013-1051","article-title":"Clinical relevance of combined FSH and AMH observations in infertile women.","volume":"98","author":"Gleicher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R88-3-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach.","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"R89-3-20210129","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.fertnstert.2009.07.1674","article-title":"Anti-mullerian hormone and inhibin B variability during normal menstrual cycles.","volume":"94","author":"Sowers","year":"2010","journal-title":"Fertil Steril"},{"key":"R90-3-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.fertnstert.2009.03.032","article-title":"Assay reproducibility and within-person variation of mullerian inhibiting substance.","volume":"94","author":"Dorgan","year":"2010","journal-title":"Fertil Steril"},{"key":"R91-3-20210129","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.rbmo.2012.02.023","article-title":"Intra-cycle fluctuations of anti-mullerian hormone in normal women with a regular cycle: a re-analysis.","volume":"24","author":"Overbeek","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"R92-3-20210129","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.fertnstert.2013.01.132","article-title":"Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response.","volume":"99","author":"Hadlow","year":"2013","journal-title":"Fertil Steril"},{"key":"R93-3-20210129","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/humrep\/deq071","article-title":"Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.","volume":"25","author":"Van den Berg","year":"2010","journal-title":"Hum Reprod"},{"key":"R94-3-20210129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09513590.2010.487595","article-title":"The effect of different hormone therapies on antimullerian hormone serum levels in anovulatory women of reproductive age.","volume":"27","author":"Fabregues","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"R95-3-20210129","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/uog.10114","article-title":"Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-mullerian hormone and small antral follicle count using three-dimensional ultrasound.","volume":"39","author":"Deb","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R96-3-20210129","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.fertnstert.2014.02.039","article-title":"Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients.","volume":"101","author":"Mes-Krowinkel","year":"2014","journal-title":"Fertil Steril"},{"key":"R97-3-20210129","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2012.11.034","article-title":"Antimullerian hormone levels decrease in women using combined contraception independently of administration route.","volume":"99","author":"Kallio","year":"2013","journal-title":"Fertil Steril"},{"key":"R98-3-20210129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7827-11-60","article-title":"Anti-mullerian-hormone levels during pregnancy and postpartum.","volume":"11","author":"Koninger","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"R99-3-20210129","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/acr.22013","article-title":"Levels of serum anti-mullerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis.","volume":"65","author":"Brouwer","year":"2013","journal-title":"Arthritis Care Res"},{"key":"R100-3-20210129","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.fertnstert.2007.08.032","article-title":"Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.","volume":"90","author":"Oriol","year":"2008","journal-title":"Fertil Steril"},{"key":"R101-3-20210129","first-page":"1239","article-title":"Is there a role for DHEA supplementation in women with diminished ovarian reserve J Assist Reprod G","volume":"30","author":"Fouany","year":"2013","journal-title":"enet"},{"key":"R102-3-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejogrb.2012.12.017","article-title":"DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism.","volume":"168","author":"Hyman","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R103-3-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1477-7827-11-44","article-title":"Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis.","volume":"11","author":"Narkwichean","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"R105-3-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.rbmo.2011.06.011","article-title":"The journey from the old to the new AMH assay: how to avoid getting lost in the values.","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"R106-3-20210129","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10815-012-9880-1","article-title":"Correlation between three assay systems for anti-mullerian hormone (AMH) determination.","volume":"29","author":"Li","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"R108-3-20210129","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/des260","article-title":"Anti-mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.","volume":"27","author":"Rustamov","year":"2012","journal-title":"Human Reprod"},{"key":"R109-3-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.repbio.2013.04.005","article-title":"Within-laboratory and between-laboratory variability in the measurement of antimullerian hormone determined within an external quality assurance scheme.","volume":"13","author":"Zuvela","year":"2013","journal-title":"Reprod Biol"},{"key":"R110-3-20210129","doi-asserted-by":"crossref","first-page":"165352","DOI":"10.1155\/2014\/165352","article-title":"Decreasing quality of the new generations of antimullerian hormone assays.","volume":"2014","author":"Lukaszuk","year":"2014","journal-title":"BioMed Res Int"},{"key":"R112-3-20210129","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/humrep\/deu036","article-title":"A single-centre evaluation of two new anti-mullerian hormone assays and comparison with the current clinical standard assay.","volume":"29","author":"Welsh","year":"2014","journal-title":"Hum Reprod"},{"key":"R113-3-20210129","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/humrep\/deu050","article-title":"Premixing serum samples with assay buffer is a prerequisite for reproducible anti-mullerian hormone measurement using the Beckman Coulter Gen II assay.","volume":"29","author":"Han","year":"2014","journal-title":"Hum Reprod"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0000000000000087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T14:11:35Z","timestamp":1746281495000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201408000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0000000000000087","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}